Related references
Note: Only part of the references are listed.Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer
U. De Giorgi et al.
ANNALS OF ONCOLOGY (2010)
Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy
F. -C. Bidard et al.
ANNALS OF ONCOLOGY (2010)
Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer
Edoardo Botteri et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Information from CTC measurements for metastatic breast cancer prognosis-we should do more than selecting an optimal cut point
T. Fehm et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
Tanja Fehm et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer
L. M. Flores et al.
BRITISH JOURNAL OF CANCER (2010)
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2010)
Prognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based Review
Shaheenah Dawood et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
Marta Pestrin et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer
Ugo De Giorgi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
Tanja Fehm et al.
BREAST CANCER RESEARCH (2009)
Circulating Tumor Cells in Metastatic Breast Cancer From Prognostic Stratification to Modification of the Staging System?
Shaheenah Dawood et al.
CANCER (2008)
Artifficial neural networks estimating survival probability after treatment of choroidal melanoma
Bertil Damato et al.
OPHTHALMOLOGY (2008)
Statistical considerations for enumeration of circulating tumor cells
Arjan G. J. Tibbe et al.
CYTOMETRY PART A (2007)
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer:: A validation study of the CellSearch system
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2007)
HER2/neu role in breast cancer: from a prognostic foe to a predictive friend
Gianluigi Ferretti et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2007)
Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer
G. Thomas Budd et al.
CLINICAL CANCER RESEARCH (2006)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Dichotomizing continuous predictors in multiple regression: a bad idea
P Royston et al.
STATISTICS IN MEDICINE (2006)
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment:: The M77001 study group
M Marty et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Non-linear survival analysis using neural networks
RM Ripley et al.
STATISTICS IN MEDICINE (2004)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer
V Bozionellou et al.
CLINICAL CANCER RESEARCH (2004)
HER-2 gene amplification can be acquired as breast cancer progresses
SD Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A novel neural network-based survival analysis model
A Eleuteri et al.
NEURAL NETWORKS (2003)
Share Paper
